GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HMGA1 | hg19_v2_chr6_+_34204642_34204664 | -0.23 | 5.5e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91539918 Show fit | 12.44 |
ENST00000548218.1
|
decorin |
|
chr4_+_155484155 Show fit | 11.57 |
ENST00000509493.1
|
fibrinogen beta chain |
|
chr1_+_196621002 Show fit | 11.32 |
ENST00000367429.4
ENST00000439155.2 |
complement factor H |
|
chr3_-_195310802 Show fit | 10.20 |
ENST00000421243.1
ENST00000453131.1 |
apolipoprotein D |
|
chr12_-_91546926 Show fit | 9.75 |
ENST00000550758.1
|
decorin |
|
chr2_+_189839046 Show fit | 8.60 |
ENST00000304636.3
ENST00000317840.5 |
collagen, type III, alpha 1 |
|
chr4_-_143226979 Show fit | 8.57 |
ENST00000514525.1
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
|
chr12_-_91573249 Show fit | 7.83 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
decorin |
|
chr1_+_196621156 Show fit | 7.64 |
ENST00000359637.2
|
complement factor H |
|
chr12_-_71551652 Show fit | 7.51 |
ENST00000546561.1
|
tetraspanin 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 37.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.9 | 22.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 18.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.7 | 16.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 13.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
4.0 | 12.1 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
2.0 | 11.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 10.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
3.4 | 10.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.0 | 9.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 48.0 | GO:0005615 | extracellular space(GO:0005615) |
2.9 | 41.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 22.8 | GO:0030018 | Z disc(GO:0030018) |
1.6 | 21.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.6 | 18.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 17.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 13.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 9.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.6 | 8.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 7.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 46.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 29.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 21.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 19.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 13.0 | GO:0051087 | chaperone binding(GO:0051087) |
1.1 | 12.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 12.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 10.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 10.5 | GO:0015485 | cholesterol binding(GO:0015485) |
1.9 | 9.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 44.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.7 | 41.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 20.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 15.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 11.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 9.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 5.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 5.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 39.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 21.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.3 | 21.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 17.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.0 | 16.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 15.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 9.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 8.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 8.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 8.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |